Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer



Status:Recruiting
Conditions:Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:9/5/2018
Start Date:August 30, 2018
End Date:August 30, 2020
Contact:Cheryl Kefauver, RN
Email:Cheryl.Kefauver@med.usc.edu
Phone:323-865-0459

Use our guide to learn which trials are right for you!

Evaluating Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements for Oncologic Patients - A Cross-Sectional Survey Study at Norris Comprehensive Cancer Center

This trial studies nutritional preferences and product accessibility in oral nutritional
supplements in participants with breast, colorectal, upper gastrointestinal, or prostate
cancer. Learning what participants like and dislike about their current or past used
nutritional supplements may help doctor know how to improve them.

PRIMARY OBJECTIVES:

I. Identify how patients with cancer are obtaining nutrition to support medical management.

SECONDARY OBJECTIVES:

I. Examine associations of gastrointestinal side effects with specific diagnoses and
respective medical therapies.

II. Understand how patients access information regarding nutritional supplements.

III. Evaluate patient satisfaction with currently available oral nutritional supplements
(ONS).

IV. Identify patient preferences in formulating a novel nutritional supplement.

OUTLINE:

Participants attend an interview over 15 minutes and complete surveys.

Inclusion Criteria:

- Ability to comprehend English (both reading and writing)

- Subjects in the inpatient and outpatient setting with the diagnosis of breast cancer,
colorectal cancer, upper gastrointestinal cancer (including gastric, pancreatic, and
cholangiocarcinoma), or prostate cancer

- Receiving chemotherapy, biologic, or hormonal therapy in the University of Southern
California (USC) Norris Comprehensive Cancer Center Day Hospital

- Ability to understand and the willingness to sign a written informed consent

Exclusion Criteria:

- Patients with a mental disability that makes them unable to understand and respond to
the questions

- Patients with reported non-oncologic associated deficits in taste and smell
We found this trial at
1
site
1441 Eastlake Ave
Los Angeles, California 90033
(323) 865-3000
Principal Investigator: Jacek Pinski, MD
Phone: 323-865-0459
U.S.C./Norris Comprehensive Cancer Center The USC Norris Comprehensive Cancer Center, located in Los Angeles, is...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials